AbbVie shares rose 5.5% Friday, after the company hiked its sales forecasts for two key drugs. The company reported fourth-quarter revenue and earnings above Wall Street's estimates, and forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback